Charles J Casamento - Net Worth and Insider Trading
Charles J Casamento Net Worth
The estimated net worth of Charles J Casamento is at least $954,874 dollars as of 2024-11-29. Charles J Casamento is the Director of Eton Pharmaceuticals Inc and owns about 71,920 shares of Eton Pharmaceuticals Inc (ETON) stock worth over $916,261. Charles J Casamento is the Director of Relmada Therapeutics Inc and owns about 13,000 shares of Relmada Therapeutics Inc (RLMD) stock worth over $37,700. Charles J Casamento is also the Director of VIVUS Inc and owns about 6,600 shares of VIVUS Inc (VVUSQ) stock worth over $775. Besides these, Charles J Casamento also holds Entero Therapeutics Inc (ENTO) . Details can be seen in Charles J Casamento's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Charles J Casamento has not made any transactions after 2024-09-09 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Charles J Casamento
Charles J Casamento Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Charles J Casamento owns 9 companies in total, including Relmada Therapeutics Inc (RLMD) , Entero Therapeutics Inc (ENTO) , and Eton Pharmaceuticals Inc (ETON) among others .
Click here to see the complete history of Charles J Casamento’s form 4 insider trades.
Insider Ownership Summary of Charles J Casamento
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| RLMD | Relmada Therapeutics Inc | 2024-09-09 | director |
| ENTO | Entero Therapeutics Inc | 2023-09-15 | director |
| ETON | Eton Pharmaceuticals Inc | 2019-08-09 | director |
 | | 2010-06-21 | director |
| | 2013-01-25 | director |
| | 2003-12-09 | director |
| | 2006-10-05 | director & CEO & President |
| | 2023-05-01 | director |
| | 2023-10-02 | director |
Charles J Casamento Latest Holdings Summary
Charles J Casamento currently owns a total of 4 stocks. Among these stocks, Charles J Casamento owns 71,920 shares of Eton Pharmaceuticals Inc (ETON) as of August 9, 2019, with a value of $916,261 and a weighting of 95.96%. Charles J Casamento owns 13,000 shares of Relmada Therapeutics Inc (RLMD) as of September 9, 2024, with a value of $37,700 and a weighting of 3.95%. Charles J Casamento also owns 6,600 shares of VIVUS Inc (VVUSQ) as of August 20, 2012, with a value of $775 and a weighting of 0.08%. The other 1 stocks Entero Therapeutics Inc (ENTO) have a combined weighting of 0.01% among all his current holdings.
Latest Holdings of Charles J Casamento
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ETON | Eton Pharmaceuticals Inc | 2019-08-09 | 71,920 | 12.74 | 916,261 |
| RLMD | Relmada Therapeutics Inc | 2024-09-09 | 13,000 | 2.90 | 37,700 |
| VVUSQ | VIVUS Inc | 2012-08-20 | 6,600 | 0.12 | 775 |
| ENTO | Entero Therapeutics Inc | 2023-09-15 | 305 | 0.45 | 139 |
Holding Weightings of Charles J Casamento
Charles J Casamento Form 4 Trading Tracker
According to the SEC Form 4 filings, Charles J Casamento has made a total of 0 transactions in Eton Pharmaceuticals Inc (ETON) over the past 5 years. The most-recent trade in Eton Pharmaceuticals Inc is the acquisition of 3,500 shares on August 9, 2019, which cost Charles J Casamento around $21,385.
According to the SEC Form 4 filings, Charles J Casamento has made a total of 13 transactions in Relmada Therapeutics Inc (RLMD) over the past 5 years, including 1 buys and 12 sells. The most-recent trade in Relmada Therapeutics Inc is the acquisition of 13,000 shares on September 9, 2024, which cost Charles J Casamento around $33,280.
According to the SEC Form 4 filings, Charles J Casamento has made a total of 0 transactions in VIVUS Inc (VVUSQ) over the past 5 years. The most-recent trade in VIVUS Inc is the sale of 800 shares on August 20, 2012, which brought Charles J Casamento around $165,040.
More details on Charles J Casamento's insider transactions can be found in the Insider Trading History of Charles J Casamento table.Insider Trading History of Charles J Casamento
- 1
Charles J Casamento Trading Performance
GuruFocus tracks the stock performance after each of Charles J Casamento's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Charles J Casamento is 9.72%. GuruFocus also compares Charles J Casamento's trading performance to market benchmark return within the same time period. The performance of stocks bought by Charles J Casamento within 3 months outperforms 2 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Charles J Casamento's insider trading performs compared to the benchmark.
Performance of Charles J Casamento
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 9.37 | | | | | |
| Relative Return to S&P 500(%) | 8.46 | | | | | |
Charles J Casamento Ownership Network
Charles J Casamento Owned Company Details
What does Relmada Therapeutics Inc do?
Who are the key executives at Relmada Therapeutics Inc?
Charles J Casamento is the director of Relmada Therapeutics Inc. Other key executives at Relmada Therapeutics Inc include director & Chief Executive Officer Sergio Traversa , Chief Financial Officer Chuck Ence , and Chief Medical Officer Cedric O'gorman .
Relmada Therapeutics Inc (RLMD) Insider Trades Summary
Over the past 18 months, Charles J Casamento made 1 insider transaction in Relmada Therapeutics Inc (RLMD) with a net purchase of 13,000. Other recent insider transactions involving Relmada Therapeutics Inc (RLMD) include a net purchase of 240,000 shares made by Sergio Traversa , a net purchase of 86,107 shares made by Maged Shenouda , and a net purchase of 38,970 shares made by Chuck Ence .
In summary, during the past 3 months, insiders sold 0 shares of Relmada Therapeutics Inc (RLMD) in total and bought 231,432 shares, with a net purchase of 231,432 shares. During the past 18 months, 0 shares of Relmada Therapeutics Inc (RLMD) were sold and 403,077 shares were bought by its insiders, resulting in a net purchase of 403,077 shares.
Relmada Therapeutics Inc (RLMD)'s detailed insider trading history can be found in Insider Trading Tracker table.
Relmada Therapeutics Inc Insider Transactions
Charles J Casamento Mailing Address
Above is the net worth, insider trading, and ownership report for Charles J Casamento. You might contact Charles J Casamento via mailing address: 99 Belbrook Way, Atherton Ca 94027.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
